Post-Operative Cataract Surgery Inflammation Treatment Market
Key Insight
The post-operative cataract surgery inflammation treatment market is projected to grow from USD 5.2 billion in 2025 to USD 10.0 billion by 2035, at a CAGR of 6.8%. Bromfenac will dominate with a 41.7% market share, while oral will lead the route of administration segment with a 58.6% share.